Tuukka Antero Helin (Tuukka Helin, Tuukka A Helin)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 9

Top Topics

Oral Anticoagulants

Venous Thromboembolism

Top Venues

Diagnostics (Basel, Switzerland)

Research and practice in thrombosis and haemostasis

Scandinavian journal of clinical and laboratory investigation

This page only lists publications with an associated author ORCID identifier.

Publications

Tuukka Antero Helin, Tomi Tirri, Heidi Korkala, Kimmo Lappalainen, Lotta Joutsi-Korhonen
Laboratory Assessment of Unfractionated Heparin (UFH) with Activated Clotting Time (ACT) and Anti-Xa Activity during Peripheral Arterial Angiographic Procedure. Diagnostics (Basel, Switzerland) 13 (8) (2023)
Tuukka Antero Helin, Pekka Raatikainen, Mika Lehto, Jari K Haukka, Riitta Lassila
Associations of anaemia with bleeding and thrombotic complications in patients with atrial fibrillation treated with warfarin: a registry-based nested case-control study. BMJ open 13 (11) (2023)
Tuukka Antero Helin, Tomi Tirri, Heidi Korkala, Kimmo Lappalainen, Lotta Joutsi-Korhonen
Laboratory Assessment of Unfractionated Heparin (UFH) with Activated Clotting Time (ACT) and Anti-Xa Activity during Peripheral Arterial Angiographic Procedure. Diagnostics (Basel, Switzerland) 13 (8) (2023)
Paula Savola, Marja Lemponen, Lotta Joutsi-Korhonen, Tuukka Antero Helin
Novel Ex Vivo DOAC Removal Methods Reduce Interference in Lupus Anticoagulant Testing. Diagnostics (Basel, Switzerland) 12 (10) (2022)
Tuukka Antero Helin, Marja Lemponen, Tapio Lahtiharju, Miika Koskinen, Riitta Lassila, Lotta Joutsi-Korhonen
Anaemia and enhancement of coagulation are associated with severe COVID-19 infection. Scandinavian journal of clinical and laboratory investigation (2021)
Tuukka Antero Helin, Marja Lemponen, Riitta Lassila, Lotta Joutsi-Korhonen
Comparison of novel thrombin generation methods with established techniques is mandatory. Research and practice in thrombosis and haemostasis 5 (4) (2021)
Tuukka Antero Helin, Marja Lemponen, Riitta Lassila, Lotta Joutsi-Korhonen
Anticoagulated patients exhibit intact endogenous thrombin potential using ST Genesia unlike the Calibrated Automated Thrombogram. Research and practice in thrombosis and haemostasis 5 (3) (2021)
Tuukka Antero Helin, Lotta Joutsi-Korhonen, Heidi Asmundela, Mikko Niemi, Arto Orpana, Riitta Lassila
Warfarin dose requirement in patients having severe thrombosis or thrombophilia. British journal of clinical pharmacology 85 (8) (2019)
Tuukka Antero Helin, Marleen Zuurveld, Mikko Manninen, Joost C M Meijers, Riitta Lassila, Herm Jan M Brinkman
Hemostatic profile under fluid resuscitation during rivaroxaban anticoagulation: an in vitro survey. Transfusion 58 (12) (2018)